Friday, February 07, 2020 12:09:01 PM
There is nothing to support that conclusion IMO. The company business model has failed to date, nothing more, nothing less.
Several folks have reported the company to the AZ DA, to the SEC to the FBI and nothing has been found because there is nothing to be found IMO.
CELZ has not been commercially successful because they have not sold enough kits. IMO, that was due to the delays between CaverStem and CaverStem 2.0 and paper being extended a year to include the first 100 2.0 patients. It’s simple math, clear as the day is long.
As an example, if I open a restaurant and it is not successful and goes out of business, did I committed a fraud? Of course not. CELZ could go out of business too, who knows, but I see no FRAUD.
Companies fail all the time and many struggle before they succeed. That is what is happening here IMO. If CELZ was a fraud, they would have NO patents, NO trademarks, NO clinical trial paper, NO physicians etc. they would have pumped out tons of promising pressers and diluted as fast as possible. All CELZ has done is to start up way too slow, not have enough revs, and was forced to issues small notes for under $300k at a time every few months to stay alive. Those notes cost them severely as they death spiraled, and we all know fuel was added to the fire.
Someone show me one piece of EVIDENCE it is a FRAUD and I will listen. The long investors choose to remain optimistic for two reasons. One is the science. It is PROVEN and it will be successful. Investors are betting CELZ will be part of it. The other is my cash is riding on it. Why would I post negativity about own investment? That makes zero financial sense and seems counterintuitive.
Show me CELZ is a FRAUD and I will join the fight. In the meantime, I will wait and see how many doctors sign up now that the Clinical Review paper is out. We have seen two offices open already. When will they announce the buzz we know is brewing about StemSpine? Will they work out a deal on AmnioStem as they reported? Who knows, but I can look up the patents and know those are all for real. No scam, no fraud, just not successful yet. That is how I see it until proven otherwise.
Recent CELZ News
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 10/23/2024 08:27:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2024 08:23:39 PM
- Creative Medical Technology Holdings Announces $1.85 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 10/23/2024 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 10/16/2024 04:15:14 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 10/04/2024 08:45:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:45:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 08:10:25 PM
- Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program • GlobeNewswire Inc. • 07/24/2024 01:00:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • GlobeNewswire Inc. • 07/10/2024 12:30:00 PM
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM